Decongestants for in children under 2 and antihistamines in those younger than 6, may be banned, according to agency documents released Friday, the Associated Press reported.

The ban may involved oer 800 popular medicines sold in the United States under names like Toddler's Dimetapp, Triaminic Infant and Little Colds, The New York Times reported.

FDA experts recommended that all infant cough and cold products be removed from the market.

They also recommended that the sizes of the droppers, cups and syringes packaged with products be standardized to reduce the possibility of confusion and overdose, the Times said.

An FDA review of records filed with the agency between 1969 and September 2006 found 54 reports of deaths in children associated with decongestant medicines made with pseudoephedrine, phenylephrine or ephedrine.

69 reports of deaths were associated with antihistamine medicines containing diphenhydramine, brompheniramine or chlorpheniramine, the AP said.

Most of the deaths were children younger than 2.